ALKEM LABORATORIES Announces Quarterly Results (4QFY21); Net Profit Up 30.1%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES Announces Quarterly Results (4QFY21); Net Profit Up 30.1%
Thu, 8 Jul

ALKEM LABORATORIES has announced its results for the quarter ended March 2021. Here is a detailed performance review of the same:

ALKEM LABORATORIES Quarterly Financials

No. of Mths
Qtr. Ending
3
Mar-20*
3
Dec-20*
3
Mar-21*
QoQ ChangeYoY Change
Net SalesRs m20,49023,18121,922-5.4%7.0%
Other incomeRs m275964463-52.0%68.5%
TurnoverRs m20,76524,14522,384-7.3%7.8%
ExpensesRs m17,46017,88919,0116.3%8.9%
Gross profitRs m3,0305,2912,911-45.0%-3.9%
DepreciationRs m811690685-0.7%-15.5%
InterestRs m142131107-18.1%-24.3%
Profit before taxRs m2,3535,4342,582-52.5%9.7%
TaxRs m43879689-88.8%-79.6%
Profit after taxRs m1,9154,6392,492-46.3%30.1%
Gross profit margin%14.822.813.3
Effective tax rate%18.614.63.5
Net profit margin%9.219.211.1
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 7.0% on a year-on-year (YoY) basis. The expenses were up by 8.9% YoY during the same period.
  • The company's operating profit declined by 3.9% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 13.3% in 4QFY21 as against 14.8% in 4QFY20.
  • Depreciation charges declined by 15.5% and finance costs declined by 24.3% YoY, respectively.
  • Other income increased by 68.5% YoY during the quarter.
  • Net profit for the quarter increased by 30.1% YoY. Net profit margins during the quarter increased from 9.2% in 4QFY20 to 11.1% in 4QFY21.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 5.4% on a quarter-on-quarter (QoQ) basis. The expenses were up by 6.3% QoQ during the same period.
  • The company's operating profit declined by 45.0% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 13.3% in 4QFY21 as against 22.8% in 3QFY20.
  • Net profit for the quarter declined by 46.3% QoQ, while net profit margins declined from 19.2% in 3QFY20 to 11.1% in 4QFY21.

To see how ALKEM LABORATORIES has performed over the last eight quarters,please visit here.

FREE REPLAY: Catch the Details of Potential Crorepati-Making Stocks Right Now...

ALKEM LABORATORIES Share Price Performance

Over the last one year, ALKEM LABORATORIES share price has moved up from Rs 2,428.2 to Rs 3,323.3, registering a Gain of Rs 895.1 or around 36.9%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 25,667.5 (down 1.1%). Over the last one year it has moved up from 16,363.1 to 25,667.5, a gain of 9,304 points (up 56.9%).

Overall, the S&P BSE SENSEX is up 43.8% over the year.

Current Valuations

At the current price of Rs 3,323.3, the price to earnings (P/E) ratio of ALKEM LABORATORIES stands at 24.6 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 6.5 times.

Equitymaster requests your view! Post a comment on "ALKEM LABORATORIES Announces Quarterly Results (4QFY21); Net Profit Up 30.1%". Click here!

  

Related Views on News

ALKEM LABORATORIES Announces Quarterly Results (1QFY22); Net Profit Up 13.5% (Quarterly Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

For the quarter ended June 2021, ALKEM LABORATORIES has posted a net profit of Rs 5 bn (up 13.5% YoY). Sales on the other hand came in at Rs 27 bn (up 37.1% YoY). Read on for a complete analysis of ALKEM LABORATORIES's quarterly results.

ALKEM LABORATORIES 2020-21 Annual Report Analysis (Annual Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

Here's an analysis of the annual report of ALKEM LABORATORIES for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of ALKEM LABORATORIES. Also includes updates on the valuation of ALKEM LABORATORIES.

More Views on News

Most Popular

India's Best Semiconductor Stocks(Views On News)

Jan 7, 2022

Modern wars are fought with semiconductors. India's best semiconductor stocks have big tailwinds from defence and manufacturing.

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Jan 20, 2022 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 5-YR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS